Skip to main content
Clinical Trials/JPRN-UMIN000020027
JPRN-UMIN000020027
Completed
未知

Effect of SGLT2 inhibitor, canagliflozin, for the size of lipid particles - Effect of canagliflozin for the size of lipid particles

Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy0 sites30 target enrollmentFebruary 1, 2016
ConditionsType 2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2016
End Date
January 23, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) History of hypersensitivity of canagliflozin 2\) Severe ketosis, diabetic coma or precoma 3\) Severe infection, pre or post surgery, or severe trauma 4\) Patients taking fibrate\-based medicines or pioglitazone 5\) Patients taking diuretic medicines 6\) eGFR \< 45 mL/min/1\.73 m2 or artificial dialysis 7\) Considered as inadequate by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials